BioSpace News Archive

Zhittya Genesis Medicine, Inc., announced that it has completed its first-in-human research study for the treatment of Parkinson’s disease.

Upsher-Smith Laboratories, LLC announced that it has been honored with a Distribution Industry Award for Notable Achievement in Healthcare for “Best Overall Branded Pharmaceutical Product Manufacturer with less than $300M in sales” by the Healthcare Distribution Alliance.

Athersys, Inc., a regenerative medicine company developing MultiStem® for critical care indications, announced it will host a panel discussion with leading neurology experts on Tuesday, June 14th at 5:00 p.m. ET.

Typenex® Medical LLC, a pioneer in patient identification solutions, has been awarded a three-year group purchasing contract with Premier, Inc., a leading healthcare improvement company.

Gritstone bio, Inc. announced that the company’s Board of Directors has granted eighteen employees nonqualified stock options to purchase an aggregate of 206,550 shares of its common stock with an exercise price of $1.85, which is equal to the closing price of Gritstone’s common stock on May 27, 2022, the grant date of the awards.

HTG Molecular Diagnostics, Inc. announced that it will be sponsoring a keynote presentation at the 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference in San Diego, CA, titled “Implementing Biomarker Strategy in Clinical Trials” on June 16th at 9:05 AM PT.

MacroGenics, Inc., a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, announced that the Company’s management will participate in the following investor conference in June 2022.

Tonix Pharmaceuticals Holding Corp. announced that Tom Hobman, Ph.D., Professor, Department of Cell Biology, University of Alberta, presented data from his laboratory at The University of Alberta as a keynote presentation at the 4th Symposium of the Canadian Society for Virology held in Edmonton, Alberta, Canada on June 5, 2022.

OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced that on June 4, 2022, OraSure’s Board of Directors granted Carrie Eglinton Manner, the Company’s newly appointed President and Chief Executive Officer, an inducement award.

Opiant Pharmaceuticals, Inc. announced a capacity investment agreement with Aptar Pharma, a leading provider of drug delivery systems, to expand production of Aptar’s nasal Unidose device, which will be used in the production of commercial supply of OPNT003, nasal nalmefene.